XML 52 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill - Additional Information (Detail)
12 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended
Dec. 31, 2013
USD ($)
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
May 29, 2013
PriceSpective LLC
USD ($)
Aug. 13, 2012
PriceSpective LLC
USD ($)
Feb. 28, 2012
PriceSpective LLC
USD ($)
Feb. 28, 2012
PriceSpective LLC
Initial
USD ($)
Feb. 28, 2012
PriceSpective LLC
Maximum
USD ($)
Jun. 13, 2013
BeijingWits Medical Limited
USD ($)
Feb. 15, 2012
BeijingWits Medical Limited
USD ($)
Dec. 31, 2013
BeijingWits Medical Limited
USD ($)
Feb. 15, 2012
BeijingWits Medical Limited
Maximum
USD ($)
Feb. 15, 2012
BeijingWits Medical Limited
Minimum
Employee
Jul. 31, 2012
Firecrest Clinical Limited
USD ($)
Jul. 31, 2012
Firecrest Clinical Limited
EUR (€)
Mar. 31, 2012
Firecrest Clinical Limited
USD ($)
Mar. 31, 2012
Firecrest Clinical Limited
EUR (€)
Jul. 14, 2011
Firecrest Clinical Limited
USD ($)
Jul. 14, 2011
Firecrest Clinical Limited
EUR (€)
Sep. 30, 2013
Firecrest Clinical Limited
USD ($)
Sep. 30, 2013
Firecrest Clinical Limited
EUR (€)
Jul. 14, 2011
Firecrest Clinical Limited
Maximum
USD ($)
Jul. 14, 2011
Firecrest Clinical Limited
Maximum
EUR (€)
Feb. 15, 2013
Clinical Trial Services
USD ($)
Dec. 31, 2013
Clinical Trial Services
USD ($)
Oct. 30, 2013
Clinical Trial Services
USD ($)
Dec. 31, 2013
Clinical Trial Services
Maximum
USD ($)
Goodwill [Line Items]                                                      
Cash consideration $ 93,553,000 $ 72,508,000 $ 69,836,000     $ 37,199,000 $ 37,100,000     $ 9,000,000               $ 24,463,000 € 17,000,000         $ 51,897,000      
Additional consideration 3,245,000 45,850,000       15,000,000   15,000,000   7,000,000 3,200,000 7,000,000           44,028,000 31,300,000 13,200,000 10,000,000 46,800,000 33,000,000       3,750,000
Reduction in additional consideration                                                 3,750,000    
Working capital adjustment           101,000                   500,000 400,000             (199,000)   199,000  
Percentage of common stock acquired           100.00%       100.00%               100.00% 100.00%                
Further consideration paid in relation to certain performance milestones achieved       $ 10,000,000 $ 5,000,000       $ 3,800,000         $ 12,500,000 € 10,000,000 $ 4,000,000 € 3,000,000                    
Addition of new employees                         100